510(k) Report

510(k) · Cleared

Cleared

Ascensia Breeze Blood Glucose Meter

K024062510(k) TraditionalCleared Mar 3, 200384-day reviewClass II21 CFR 862.1345

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Bayer Corp. · CGA Glucose Oxidase, Glucose

Cleared on Mar 3, 2003 after an 84-day review. The FDA summary names its predicate without a number. 4 later devices descend from it.

Decided
Mar 3, 2003
Review
84 days
Class
Class II
Product code
CGA
Recalls
None
Predicates
0

4 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2006: 1 descendant cleared2008: 2 descendants cleared2013: 1 descendant cleared200020052010201520202025
  1. This deviceK024062 Ascensia Breeze Blood Glucose MeterBayer Corp. · 2003
  2. Descendant · cites it directly · 3 of its ownK062347 Ascensia Breeze 2 Blood Glucose Monitoring SystemBayer Healthcare, LLC · 2006
  3. Descendant · 2 generations on · 1 of its ownK082395 Glucose Meter-Check Control Solution for Bayer Ascensia Blood…Bionostics, Inc. · 2008
  4. Descendant · 3 generations on · 0 of its ownK123966 Glucose Meter-Check Solution for BayerBionostics, Inc. · 2013
  5. Descendant · 2 generations on · 0 of its ownK080273 AB-Trol and Private Label Glucose Control SolutionFujirebio Diagnostics Texas, Inc. · 2008

Most influential descendants

Showing 4 of 4 · See all
  • K062347Ascensia Breeze 2 Blood Glucose Monitoring SystemBayer Healthcare, LLC · 2006 · cites it directly3descendants
  • K082395Glucose Meter-Check Control Solution for Bayer Ascensia Blood Glucose Meter, Model: MC002Bionostics, Inc. · 2008 · 2 generations on1descendant
  • K123966Glucose Meter-Check Solution for BayerBionostics, Inc. · 2013 · 3 generations on0descendants
  • K080273AB-Trol and Private Label Glucose Control SolutionFujirebio Diagnostics Texas, Inc. · 2008 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K024062Ascensia Breeze Blood Glucose MeterBayer Corp.2003—
+1K062347Ascensia Breeze 2 Blood Glucose Monitoring SystemBayer Healthcare, LLC2006—
+2K082395Glucose Meter-Check Control Solution for Bayer Ascensia Blood Glucose Meter…Bionostics, Inc.2008—
+3K123966Glucose Meter-Check Solution for BayerBionostics, Inc.2013—
+2K080273AB-Trol and Private Label Glucose Control SolutionFujirebio Diagnostics Texas, Inc.2008—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200610
200820
201310
FIG. 1 — Lineage of K024062, 2003–2013Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CGA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CGA device

  1. #1 K252488 ABL90 FLEX PLUS Systemscore 12.8 · 6 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—ASCENSIA DEX 2 Blood Glucose Meter
Named without a submission number
—

What descends from it? (4)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K062347Ascensia Breeze 2 Blood Glucose Monitoring SystemBayer Healthcare, LLC20063

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K062347 (Bayer Healthcare, LLC, 2006) has gone furthest, with 3 descendants of its own.

How does its category compare?

All CGA devices

CGA Glucose Oxidase, Glucose: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · CGA

2in 2024

2007: 72008: 62009: 102010: 82011: 92012: 102013: 32014: 52015: 42016: 42017: 22018: 22019: 22020: 22021: 12022: 12023: 42024: 22026 (partial year): 1
2007high 10 (2009) · low 0 (2025)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CGA

249in 2023

2007: 122 days median2008: 56 days median2009: 155 days median2010: 122 days median2011: 217 days median2012: 123 days median2013: 441 days median2014: 265 days median2015: 150 days median2016: 157 days median2023: 249 days median
2007high 441 (2013) · low 56 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CGA

3in 2023

2007: 22008: 22009: 42010: 62011: 32013: 32014: 22015: 6, 2 Class I2016: 22019: 12023: 3
2007high 6 (2010) · low 0 (2012)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · CGA

59in 2025

2007: 292008: 372009: 752010: 1722011: 4232012: 2332013: 1722014: 1222015: 1552016: 362017: 922018: 692019: 1162020: 682021: 482022: 2722023: 1,1412024: 2662025: 59
2007high 1,141 (2023) · low 29 (2007)2025

MAUDE reports naming product code CGA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20077122229
2008656237
200910155475
201081226172
201192173423
2012101230233
201334413172
201452652122
201541506 (2)155
20164157236
20172—092
20182—069
20192—1116
20202—068
20211—048
20221—0272
2023424931,141
20242—0266
20250—059
20261—0—

What is it indicated for?

The ASCENSIA BREEZE Blood Glucose Meter is used with the ASCENSIA AUTODISC Blood Glucose Test Strips and ASCENSIA AUTODISC CONTROLS for the measurement of glucose in whole blood. The ASCENSIA BREEZE Blood Glucose Meter is a n Over-the-counter (OTC) device used by persons with diabetes and by healthcare professionals in home settings.

The ASCENSIA BREEZE Blood Glucose System is indicated for use with venous, and capillary whole blood samples drawn from the fingertip, palm, forearm, abdomen and thigh.

The frequent monitoring of blood glucose is an adjunct to the care of persons with diabetes.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K024062: Ascensia Breeze Blood Glucose Meter.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K024062

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026